Logo image of IDXX

IDEXX LABORATORIES INC (IDXX) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:IDXX - US45168D1046 - Common Stock

725.91 USD
+36.56 (+5.3%)
Last: 11/21/2025, 8:00:02 PM
725.91 USD
0 (0%)
After Hours: 11/21/2025, 8:00:02 PM

IDXX Key Statistics, Chart & Performance

Key Statistics
Market Cap58.07B
Revenue(TTM)4.17B
Net Income(TTM)1.03B
Shares80.00M
Float79.45M
52 Week High735.59
52 Week Low356.14
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)12.61
PE57.57
Fwd PE50.24
Earnings (Next)02-02 2026-02-02/amc
IPO1991-06-21
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


IDXX short term performance overview.The bars show the price performance of IDXX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30 40

IDXX long term performance overview.The bars show the price performance of IDXX in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60

The current stock price of IDXX is 725.91 USD. In the past month the price increased by 13.27%. In the past year, price increased by 73.98%.

IDEXX LABORATORIES INC / IDXX Daily stock chart

IDXX Latest News, Press Relases and Analysis

IDXX Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 25.67 222.97B
ISRG INTUITIVE SURGICAL INC 65.23 201.33B
BSX BOSTON SCIENTIFIC CORP 32.84 143.55B
SYK STRYKER CORP 27.96 140.79B
BDX BECTON DICKINSON AND CO 13.36 55.24B
EW EDWARDS LIFESCIENCES CORP 33.12 49.98B
RMD RESMED INC 25.33 36.59B
GEHC GE HEALTHCARE TECHNOLOGY 16.66 34.90B
DXCM DEXCOM INC 32.38 23.62B
PODD INSULET CORP 72.47 23.31B
ZBH ZIMMER BIOMET HOLDINGS INC 11.39 18.26B
HOLX HOLOGIC INC 17.41 16.54B

About IDXX

Company Profile

IDXX logo image IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.

Company Info

IDEXX LABORATORIES INC

One Idexx Drive

Westbrook MAINE 04092 US

CEO: Jonathan J. Mazelsky

Employees: 11000

IDXX Company Website

IDXX Investor Relations

Phone: 12075560300

IDEXX LABORATORIES INC / IDXX FAQ

What does IDEXX LABORATORIES INC do?

IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.


Can you provide the latest stock price for IDEXX LABORATORIES INC?

The current stock price of IDXX is 725.91 USD. The price increased by 5.3% in the last trading session.


What is the dividend status of IDEXX LABORATORIES INC?

IDXX does not pay a dividend.


What is the ChartMill rating of IDEXX LABORATORIES INC stock?

IDXX has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 7 out of 10.


On which exchange is IDXX stock listed?

IDXX stock is listed on the Nasdaq exchange.


What is the employee count for IDXX stock?

IDEXX LABORATORIES INC (IDXX) currently has 11000 employees.


Who owns IDEXX LABORATORIES INC?

You can find the ownership structure of IDEXX LABORATORIES INC (IDXX) on the Ownership tab.


IDXX Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to IDXX. When comparing the yearly performance of all stocks, IDXX is one of the better performing stocks in the market, outperforming 93.37% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

IDXX Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to IDXX. IDXX scores excellent points on both the profitability and health parts. This is a solid base for a good stock.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

IDXX Financial Highlights

Over the last trailing twelve months IDXX reported a non-GAAP Earnings per Share(EPS) of 12.61. The EPS increased by 15.16% compared to the year before.


Industry RankSector Rank
PM (TTM) 24.65%
ROA 30.34%
ROE 65.81%
Debt/Equity 0.53
Chartmill High Growth Momentum
EPS Q2Q%21.43%
Sales Q2Q%13.29%
EPS 1Y (TTM)15.16%
Revenue 1Y (TTM)8.39%

IDXX Forecast & Estimates

22 analysts have analysed IDXX and the average price target is 773.18 USD. This implies a price increase of 6.51% is expected in the next year compared to the current price of 725.91.

For the next year, analysts expect an EPS growth of 14.37% and a revenue growth 9.1% for IDXX


Analysts
Analysts80
Price Target773.18 (6.51%)
EPS Next Y14.37%
Revenue Next Year9.1%

IDXX Ownership

Ownership
Inst Owners97.04%
Ins Owners0.2%
Short Float %2.16%
Short Ratio3.63